Concepedia

Further Studies to Support the Use of Coproporphyrin I and III as Novel Clinical Biomarkers for Evaluating the Potential for Organic Anion Transporting Polypeptide 1B1 and OATP1B3 Inhibition

Hong Shen, Lisa J. Christopher, Yurong Lai, Jiachang Gong, Hamza Kandoussi, Samira M. Garonzik, Vidya Perera, Τushar Garimella, W. Griffith Humphreys

Drug Metabolism and Disposition · 2018 · 55 citations · 35 references

Open access

References

35

Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment

Eminy H.Y. Lee, S RYAN, Bruce K. Birmingham et al. · Clinical Pharmacology & Therapeutics · 2005 · 473 citations

Effect of OATP1B Transporter Inhibition on the Pharmacokinetics of Atorvastatin in Healthy Volunteers

Yvonne Lau, Yong Huang, Lynda Frassetto et al. · Clinical Pharmacology & Therapeutics · 2006 · 324 citations

Evidence for inverse effects of OATP-C (SLC21A6) *5 and *1b haplotypes on pravastatin kinetics

J Mwinyi · Clinical Pharmacology & Therapeutics · 2004 · 292 citations

Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPK

Christian Wagner, Ping Zhao, Y. Pan et al. · CPT Pharmacometrics & Systems Pharmacology · 2015 · 267 citations · Full text

Identification of the Rate-Determining Process in the Hepatic Clearance of Atorvastatin in a Clinical Cassette Microdosing Study

Kazuya Maeda, Yasumasa Ikeda, Tomoe Fujita et al. · Clinical Pharmacology & Therapeutics · 2011 · 207 citations